Karyopharm 8K Filing
Karyopharm Therapeutics files 8K with SEC, disclosing changes in executive compensation and shareholder vote results. The filing also includes financial statements and exhibits.
Filed: 2026-05-28 AccNo: 0001503802-26-000027 Size: 233 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits